Aptevo Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Aptevo Therapeutics shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Aptevo Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aptevo Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aptevo Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $342 | 1.9k | 0.18 |
| 2023-09-30 | $628 | 1.9k | 0.33 |
| 2022-03-31 | $1.0k | 204 | 4.90 |
| 2020-06-30 | $0 | 7 | 0.00 |
| 2020-03-31 | $0 | 9 | 0.00 |